Same Indication

Moxifloxacin vs Nivolumab

Moxifloxacin vs Nivolumab: Overview

This comparison examines the pharmacological differences between Moxifloxacin and Nivolumab.

Mechanism of Action

Moxifloxacin: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Moxifloxacin — 12 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Moxifloxacin — C21H24FN3O4.

Molecular Weight: Moxifloxacin — 401.4350 g/mol.

Type: Moxifloxacin — Small molecule; Nivolumab — Antibody.